SPA
NAGE

Sherbrooke Park Advisers’s Niagen Bioscience NAGE Stock Holding History

Sherbrooke Park Advisers’s Portfolio NAGE Stock Details NAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$99.2K Buy
+15,603
New +$109K 0.26% 133
2025
Q3 		– Sell
-17,656
Closed -$254K – 756
2025
Q2 		$254K Sell
17,656
-14,612
-45% -$144K 0.11% 339
2025
Q1 		$223K Buy
32,268
+14,552
+82% +$91.4K 0.1% 397
2024
Q4 		$94K Buy
+17,716
New +$97K 0.03% 678

Other funds holding NAGE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
Tieton Capital Management Yakima, Washington $348M AUM 45.13% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Sherbrooke Park Advisers's NAGE Position: Q4 2025 in Review

Sherbrooke Park Advisers opened a new position in Niagen Bioscience (NAGE) in Q4 2025: 15,603 shares worth $99.2K. The stake represents 0.26% of the portfolio and ranks #133 among its holdings. This is a return to the name: Sherbrooke Park Advisers previously reported a position in NAGE as recently as Q2 2025.

Sherbrooke Park Advisers first reported a position in NAGE in Q4 2024 and has held it in 4 quarters since. The position peaked at $254K in Q2 2025. 169 funds tracked by Wall St. Rank hold NAGE as of Q4 2025.

  • Sherbrooke Park Advisers held 15,603 shares of Niagen Bioscience worth $99.2K as of Q4 2025.
  • Niagen Bioscience was a new Sherbrooke Park Advisers position in Q4 2025.
  • Niagen Bioscience made up 0.26% of Sherbrooke Park Advisers's portfolio in Q4 2025, its #133 holding.
  • Sherbrooke Park Advisers first reported a position in Niagen Bioscience in Q4 2024 and has held it in 4 quarters since.
  • Sherbrooke Park Advisers's Niagen Bioscience position peaked at $254K in Q2 2025.
  • 169 funds tracked by Wall St. Rank held Niagen Bioscience as of Q4 2025.

Based on Sherbrooke Park Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.